Chronic, recurrent Lymphocytic Leukemia Terminated Phase Trials for Idelalisib (DB09054)

Also known as: Recurrent Chronic Lymphocytic Leukemia

IndicationStatusPhase
DBCOND0112002 (Chronic, recurrent Lymphocytic Leukemia)TerminatedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02928510Mechanisms of Idelalisib-Associated Diarrhea in Patients With Relapsed Chronic Lymphocytic Leukemia, Indolent Non-hodgkin Lymphoma, or Small Lymphocytic LymphomaBasic Science